A detailed history of Advisor Group Holdings, Inc. transactions in Longboard Pharmaceuticals, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 34,344 shares of LBPH stock, worth $2.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34,344
Previous 33,710 1.88%
Holding current value
$2.05 Million
Previous $728,000 27.47%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$17.0 - $27.03 $10,778 - $17,137
634 Added 1.88%
34,344 $928,000
Q1 2024

May 10, 2024

BUY
$18.89 - $26.06 $636,781 - $878,482
33,710 New
33,710 $728,000
Q2 2022

Aug 10, 2022

BUY
$2.96 - $5.38 $2 - $5
1 New
1 $0

Others Institutions Holding LBPH

About Longboard Pharmaceuticals, Inc.


  • Ticker LBPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,586,000
  • Market Cap $811M
  • Description
  • Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical ...
More about LBPH
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.